Channel NewsAsia |
Medtronic inks diabetes deal with Aetna
Mass Device Medtronic logo Medtronic (NYSE:MDT) said today that it inked a deal with health insurer Aetna (NYSE:AET) to measure outcomes for patients with Type 1 and Type 2 diabetes on multiple daily insulin injections. The program is designed for patients who ... Medtronic partners with Aetna on value-based diabetes program Medtronic, Aetna Announce Outcomes-Based Agreement for Diabetes Patients Medtronic deal with Aetna ties insulin pump payment to patient results |
Social Plugin